… This is one of the first clinical trials applying HIVC to treat COVID-19, and it will provide …
by COVID-19, help improve pulmonary function and reduce the risk of ARDS of COVID-19. …

… It is also inhibitory against the COVID-19 virus in vitro. The aim of this study is to assess
the efficacy and safety of remdesivir in adult patients with severe COVID-19. …

… ) has posed immense challenges for the research and medical communities. This review …
In formulating this review, we considered guidelines that provide recommendations on the …

… severe COVID-19 patients can safely be cared for outside of an ICU [12]. Here, we describe
a global population of patients with severe COVID-19, … patients with severe COVID-19 inside …

… of this study based on the positive results of a recent clinical trial, … Our goal in this study is to
examine the effects of … moderate-to-severe ARDS due to confirmed COVID-19 who still meet …

… screened 32 critically ill patients with severe COVID-19 pneumonia for a time period of
28 days using a standardized study protocol for oberservation of developement of COVID-…

… In animal models, the inactivation of ACE2 leads to severe acute pneumonitis in response to
… We believe that inhibition of bradykinin in severe COVID-19 patients could reduce the lung …

… Guidelines The recommendations in this article are largely concordant with the guidelines
for severe Covid-19 … pneumonia: a randomized clinical trial. JAMA Intern Med 2020 October …

… Submissions were made to the Research Ethics Committee (REC) and MHRA to amend
the protocol to a COVID-19 specific patient population and the protocol amendment was …

… human dental pulp stem cells (DPSCs) in treating severe pneumonia caused by COVID-19. …
, parallel group, clinical trial. Participants: Twenty serious COVID-19 cases will be enrolled in …